Tatva Chintan Pharma Chem: June ’22 Results Update
Moneylife Digital Team 01 August 2022
Tatva Chintan Pharma Chem (Tatva) reported poor numbers, yet again. Revenue declined by 17% y-o-y (year-on-year) and 10% q-o-q (quarter-on-quarter) to Rs88 crore. This was on the back of drastic drop in SDA (structure directing agent) sales. SDA sales crashed by 89% y-o-y, due to chip shortage, geo-political situation in Europe and lock-down in China because of COVID-19. The management...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Home First: Strong Growth but Loan Book Is Unseasoned
Moneylife Digital Team 01 August 2022
Home First Finance Company India Ltd (HFFC) operates in the affordable housing finance segment and targets first-time home-buyers in low- and middle-income groups. HFFC was co-founded by former chairman of Mphasis Ltd, Jaithirth...
Weekly Moneylife Indices & Sector Trends
Moneylife Digital Team 30 July 2022
INDIAN MARKET TRENDS
From 22nd July to 29 July 2022, the Sensex, NIFTY and ML Mega-cap Index rose 3% each. ML Large-cap Index rose 1%. ML Small-cap Index and ML Mid-cap Index ended flat. ML Micro-cap Index fell 2%. 
       ...
6 High-conviction Stocks of Top Mid-cap Mutual Fund Schemes
Moneylife Digital Team 30 July 2022
This week, we look at a few high-conviction stocks which are held by the top mid-cap schemes. Position-sizing or exposure or weight is one of the most important factors behind returns but not many people talk about it or pay...
Mahindra CIE: June ’22 Results Update
Moneylife Digital Team 28 July 2022
Mahindra CIE (MCIE) is part of Spain-based CIE Auto group which manufactures and supplies automotive parts to India and Europe. It posted mixed results in the second quarter of calendar year (CY) 2022 (Q2CY22) as its sales saw a...
Free Helpline
Legal Credit
Feedback